← FDA Drug Approvals (Drugs@FDA)

LATANOPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2025-04-14

Drug application

FDA Application #
ANDA219306
Application type
Abbreviated New Drug Application (Generic)
Brand name
LATANOPROST
Generic name
LATANOPROST
Active ingredients
LATANOPROST
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Prescription
Sponsor
MICRO LABS
Manufacturer
Micro Labs Limited
First approval
2025-04-14

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown